Brokers Set Expectations for Merit Medical Systems, Inc.’s Q2 2022 Earnings (NASDAQ:MMSI)

Merit Medical Systems, Inc. (NASDAQ:MMSIGet Rating) – Analysts at Oppenheimer reduced their Q2 2022 EPS estimates for shares of Merit Medical Systems in a research note issued to investors on Thursday, April 28th. Oppenheimer analyst S. Lichtman now anticipates that the medical instruments supplier will earn $0.57 per share for the quarter, down from their prior forecast of $0.67. Oppenheimer also issued estimates for Merit Medical Systems’ Q3 2022 earnings at $0.66 EPS.

Merit Medical Systems (NASDAQ:MMSIGet Rating) last issued its earnings results on Wednesday, April 27th. The medical instruments supplier reported $0.53 earnings per share for the quarter, topping analysts’ consensus estimates of $0.47 by $0.06. Merit Medical Systems had a net margin of 4.36% and a return on equity of 13.47%. During the same quarter last year, the firm earned $0.52 earnings per share.

MMSI has been the subject of a number of other research reports. Needham & Company LLC cut their target price on shares of Merit Medical Systems from $83.00 to $73.00 and set a “buy” rating for the company in a research report on Friday, February 25th. Barrington Research cut their target price on shares of Merit Medical Systems from $82.00 to $78.00 in a research report on Thursday. Raymond James cut their target price on shares of Merit Medical Systems from $73.00 to $72.00 and set an “outperform” rating for the company in a research report on Friday, February 25th. TheStreet upgraded shares of Merit Medical Systems from a “c” rating to a “b-” rating in a research report on Friday, February 25th. Finally, Piper Sandler cut their price objective on shares of Merit Medical Systems from $79.00 to $75.00 in a research report on Friday, February 25th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $74.40.

Shares of NASDAQ:MMSI opened at $62.01 on Monday. The company has a quick ratio of 1.10, a current ratio of 2.04 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $3.51 billion, a PE ratio of 73.82, a P/E/G ratio of 2.43 and a beta of 1.03. Merit Medical Systems has a twelve month low of $51.66 and a twelve month high of $73.85. The company has a 50-day moving average price of $64.89 and a two-hundred day moving average price of $63.47.

A number of large investors have recently modified their holdings of the stock. Emerald Advisers LLC raised its position in Merit Medical Systems by 10.3% in the 1st quarter. Emerald Advisers LLC now owns 558,371 shares of the medical instruments supplier’s stock worth $37,143,000 after purchasing an additional 52,020 shares during the period. Nisa Investment Advisors LLC grew its holdings in Merit Medical Systems by 27.7% in the 1st quarter. Nisa Investment Advisors LLC now owns 3,690 shares of the medical instruments supplier’s stock worth $245,000 after acquiring an additional 800 shares during the last quarter. Hardy Reed LLC bought a new stake in Merit Medical Systems in the 1st quarter worth $155,000. Comerica Bank grew its holdings in Merit Medical Systems by 1.1% in the 1st quarter. Comerica Bank now owns 248,484 shares of the medical instruments supplier’s stock worth $17,516,000 after acquiring an additional 2,594 shares during the last quarter. Finally, AMI Asset Management Corp grew its holdings in Merit Medical Systems by 5.7% in the 1st quarter. AMI Asset Management Corp now owns 142,912 shares of the medical instruments supplier’s stock worth $9,507,000 after acquiring an additional 7,763 shares during the last quarter. Institutional investors own 95.93% of the company’s stock.

About Merit Medical Systems (Get Rating)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

Read More

Earnings History and Estimates for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.